C ardiopulmonary bypass (CPB) is a process routinely used during cardiac surgery. During CPB, after aortic cross-clamping, the myocardium is cooled, arrested by means of cardioplegic solution, and deprived of its native blood. It has repeatedly been reported that endogenous catecholamines are vigorously increased during CPB. [1] [2] [3] [4] In addition, it has been demonstrated that norepinephrine is released from anoxic, isolated hearts5 and that cooling maintains elevated catecholamines in ischemic myocardium.6 Accordingly, on termination of CPB, myocardial tissue may have been exposed locally to increased catecholamine levels, and rewarmed un-cross-clamped heart is perfused by blood containing markedly elevated levels of catecholamines. Since continuous exposure of fl-adrenoceptors to P-adrenoceptor agonists (including elevation of endogenous catecholamines) causes desensitization and, finally, downregulation of 83-adrenoceptors,7-9 it may well be that the increase in catecholamines during CPB with cardioplegic cardiac arrest causes P32-adrenoceptors in circulating lymphocytes are certainly not a good model to predict 18-adrenoceptor changes in the human heart. 13 Therefore, in the present study, we determined in 12 children undergoing openheart surgery the effects of CPB with cardioplegic cardiac arrest on right atrial /8-adrenoceptor density, ,B-adrenoceptor subtype distribution, and functional responsiveness (assessed by right atrial adenylate cyclase activation by the 83-adrenoceptor agonist isoprenaline and various non-receptor-mediated activators). Methods Right atrial appendages were obtained from 12 children (six females and six males; mean age, 4.6±1.3 years; age range, 0.75-17 years) with acyanotic congenital heart disease who underwent open-heart surgery because of ventricular septal defect (n =5), atrioventricular septal defect (n =2), atrial septal defect (n = 1), tetralogy of Fallot (n=3), or aortic stenosis (n= 1).
Their parents had given informed written consent. None of the children suffered from acute heart failure or had been treated with sympathomimetic (i.e., catecholamines) or parasympathomimetic drugs for at least 3 weeks before surgery. Some children were treated with spironolactone (n=3), furosemide (n=2), and digitalis glycosides (n=3), either alone or in combination.
Anesthesiological premedication usually consisted of 50-100 ug/kg flunitrazepam p.o. administered in the evening before surgery or in the morning of surgery. The operation was carried out under neurolept anesthesia with boluses of flunitrazepam (50 pug/kg) and fentanyl (10-25 pug/kg). Pancuronium (100 ug/kg) was used as a muscle relaxant. Controlled ventilation was performed with an inspired oxygen fraction of 50-100%. In some children, isoflurane was added up to 1.0% (vol/vol). Right atrial appendages were removed immediately after installation of the CPB before the aorta was cross-clamped ("before"). The heart was arrested by a dose (30 ml/kg) of cold (40C) St 
Adenylate Cyclase Activity
Basal adenylate cyclase activity determined in membranes from "before" right atria (93.6±19 pmol cAMP formed/mg protein/min, n= 10) was nearly identical with that obtained in "after" right atria (93.9±20 pmol cAMP formed/mg protein/min). Figure 2 shows the effects of CPB with cardioplegic cardiac arrest on ,8-adrenergic (isoprenaline) as well as non-receptormediated activation of adenylate cyclase. Activation of adenylate cyclase by non-receptor-mediated activators (10 ILM GTP, 100 puM forskolin, 10 mM NaF, and 10 mM Mn21) was not significantly affected. In contrast, in all except one child, CPB reduced 13-adrenoceptormediated activation of adenylate cyclase; the net increase in adenylate cyclase activity evoked by 100 gM isoprenaline was in "after" right atrial membranes (64.4±14 pmol cAMP formed/mg protein/min) significantly lower than in "before" right atrial membranes (128.2±22 pmol cAMP formed/mg protein/min, n=10, p=0.0249). 
Discussion
In the present study, CPB and cardiac arrest by cold (40C) St. Thomas' cardioplegic solution did not affect f3-adrenoceptor number or f,: 12-adrenoceptor ratio in right atria from children undergoing corrective cardiac surgery but did significantly depress isoprenaline-induced activation of adenylate cyclase. On the other hand, activation of adenylate cyclase by 10 ,uM GTP and 10 mM NaF (which is believed, in this concentration, to activate predominantly G, with little effect on GQ19), 100 gM forskolin (acting predominantly at the catalytic unit of the enzyme but involving at least partly G20), and 10 mM Mn2, (acting at the catalytic unit of the enzyme) was not at all affected during CPB. f3-Adrenoceptor number also did not change. These results, therefore, suggest that after CPB, the relation between right atrial P-adrenoceptors and G protein has been altered in a manner compatible with an uncoupling of the f3-adrenoceptor from the G, protein-the first step in agonistinduced 18-adrenoceptor desensitization.9 In favor of this idea is the result of (unfortunately, only one was performed because of lack of tissue) one experiment performed in pooled membranes from three "before" and four "after" right atria, which revealed that in "after" right atria, the high-affinity state for isoprenaline (as assessed from competition curves with ICYP binding) that is essential for coupling 18-adrenoceptors to adenylate cyclase21 amounted only to 20.3% of the f-adrenoceptors compared with 44.8% in "before" right atria (Figure 3 ). Because we did not measure G, protein amount or function directly, we cannot fully exclude the possibility that changes in G, protein may-at least in part -contribute to the reduction in isoprenaline-induced adenylate cyclase activation after CPB.
In the human heart, adenylate cyclase is much more efficiently coupled to P2-adrenoceptors than to 13- adrenoceptors (see Reference 12) . Thus, perhaps CPBinduced decrease in isoprenaline-induced activation of adenylate cyclase reflects desensitization of mainly right atrial P2-adrenoceptors. Such a more pronounced 132-adrenoceptor desensitization would be in agreement with recently published data showing that in rats and guinea pigs during chronic isoprenaline infusion, cardiac 2-adrenoceptors are more rapidly and to a greater extent downregulated than are cardiac f1-adrenoceptors. [22] [23] [24] On the other hand, in "after" atrial membranes, the proportion of isoprenaline-induced highaffinity state of the P-adrenoceptors was markedly pmol cAMP formed/mg protein/min, i.e., 67% decrease) than the other seven children ("before" CPB: 138±31; "after" CPB: 77±+18 pmol cAMP/min/mg protein, i.e., 45% decrease). These findings therefore might be taken as an indication that during CPB, 3-adrenoceptors desensitize not only in right atria but also in left ventricular myocardium. The finding of a desensitization of cardiac 3-adrenoceptor function during CPB with cardioplegic cardiac arrest may be of clinical importance. The human heart contains only a few spare receptors for 3-adrenoceptor agonist (including endogenous catecholamines)-mediated positive inotropic effects, and nearly all receptors must be occupied to reach a maximal response. 15, 30, 31 Because of this lack of spare receptors, it is rather plausible that a reduced isoprenaline-induced activation of adenylate cyclase, which results in insufficient increases in cAMP, the second messenger for positive inotropic effects in the human heart,32 is accompanied by a reduced positive inotropic effect. In fact, it is frequently observed that during weaning from CPB and in the early phase after CPB, patients often need inotropic support that cannot be satisfactorily achieved by 3-adrenoceptor agonists.
In conclusion, in children undergoing open-heart surgery, CPB with cardioplegic cardiac arrest causes a reduction in 3-adrenoceptor-mediated activation of adenylate cyclase in a manner compatible with an uncoupling of 3-adrenoceptors from the GQ-protein-adenylate cyclase complex. As the human heart contains only a few spare receptors for 3-adrenoceptor agonists, such a 3-adrenoceptor desensitization may be the reason why many patients need inotropic support after CPB but respond only weakly to 3-adrenoceptor agonists.
